Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. C. Zappa, T. Trequattrini, F. Mattioli, R. Rivitti, S. Cardo, A. Marcoccia (Rome, Italy). Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure. Eur Respir J 2010; 36: Suppl. 54, 835

Member's Comments

No comment yet.

Related content which might interest you: Acute exacerbation of interstitial lung diseases as a cause of respiratory failure. Our 3-years experience Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Management of acute exacerbation of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=387 Year: 2006 Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus Source: Eur Respir J 2008; 31: 213-217 Year: 2008 The syndrome of respiratory failure in acute stroke patients. Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1 Year: 2020 Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Autopsy-proven pulmonary determinants in patients with acute respiratory failure Source: Annual Congress 2010 - Intensive care unit outcome Year: 2010 Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease: effects of corticosteroid Source: Eur Respir J 2002; 20: Suppl. 38, 36s Year: 2002 Potential causes of acute deterioration in patients with interstitial lung disease Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Pathogenesis of acute microvascular lung injury and the acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=22 Year: 2002 NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded) Source: Eur Respir Mon; 2008: 41: 60–71 Year: 2008 Obstructive pulmonary disease with acute respiratory failure Source: ISSN=1025-448x, ISBN=1-904097-17-0, page=11 Year: 2001 Diffuse parenchymal lung diseases presenting with acute hypoxemic failure  Source: International Congress 2017 – Pulmonary emergencies year in review Year: 2017 The effect of early pulmonary rehabilitation on the treatment of ICU chronic obstructive pulmonary disease with severe respiratory failure Source: International Congress 2018 – Muscles and diaphragm, and quality improvement Year: 2018 Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease Source: Eur Respir Rev 2009; 18: 129-132 Year: 2009 Acute effects of early mobility and respiratory therapy in hospitalised patients with chronic heart failure Source: Annual Congress 2009 - Respiratory physiotherapy assessment Year: 2009 The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome Source: Eur Respir J 2003; 21: 720-727 Year: 2003 Relationship between renal correction with chronic respiratory acidosis and prognosis in patients with chronic respiratory failure Source: Virtual Congress 2020 – Home non-invasive ventilation: (long-term) effects and prognosis Year: 2020